 Kentaro Yomogida
Concepts (441)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transcription Factors | 14 | 2023 | 1734 | 1.230 |
Why?
| | Spermatogenesis | 19 | 2013 | 91 | 0.990 |
Why?
| | Muscles | 2 | 2024 | 330 | 0.900 |
Why?
| | Testis | 28 | 2008 | 162 | 0.880 |
Why?
| | Arthritis, Juvenile | 1 | 2025 | 60 | 0.880 |
Why?
| | Synovial Membrane | 1 | 2025 | 123 | 0.840 |
Why?
| | Ice | 1 | 2024 | 16 | 0.820 |
Why?
| | Sertoli Cells | 8 | 2004 | 28 | 0.810 |
Why?
| | Intraepithelial Lymphocytes | 1 | 2023 | 17 | 0.800 |
Why?
| | T-Box Domain Proteins | 2 | 2021 | 106 | 0.700 |
Why?
| | Lymphocyte Subsets | 1 | 2021 | 77 | 0.690 |
Why?
| | Perciformes | 1 | 2020 | 20 | 0.630 |
Why?
| | Immunity, Cellular | 1 | 2021 | 274 | 0.620 |
Why?
| | Cryopreservation | 1 | 2020 | 113 | 0.580 |
Why?
| | Transcriptome | 1 | 2025 | 1038 | 0.580 |
Why?
| | Immunity, Innate | 2 | 2021 | 835 | 0.550 |
Why?
| | Interleukin-17 | 2 | 2014 | 120 | 0.470 |
Why?
| | Interleukin-2 Receptor alpha Subunit | 2 | 2013 | 82 | 0.450 |
Why?
| | Mice | 48 | 2024 | 18329 | 0.420 |
Why?
| | DNA-Binding Proteins | 12 | 2008 | 1480 | 0.410 |
Why?
| | Superantigens | 1 | 2013 | 70 | 0.390 |
Why?
| | Th1 Cells | 1 | 2013 | 139 | 0.370 |
Why?
| | Magnetic Fields | 2 | 2024 | 24 | 0.360 |
Why?
| | Streptavidin | 1 | 2012 | 15 | 0.360 |
Why?
| | Cell Polarity | 1 | 2013 | 137 | 0.360 |
Why?
| | Freezing | 2 | 2024 | 83 | 0.360 |
Why?
| | Forkhead Transcription Factors | 1 | 2013 | 207 | 0.350 |
Why?
| | Arthritis, Experimental | 1 | 2013 | 136 | 0.340 |
Why?
| | Animals | 54 | 2025 | 38030 | 0.340 |
Why?
| | Interferon-gamma | 3 | 2021 | 784 | 0.330 |
Why?
| | Interleukin-2 | 1 | 2012 | 440 | 0.320 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2013 | 409 | 0.300 |
Why?
| | Transfection | 9 | 2014 | 926 | 0.290 |
Why?
| | Lymphocyte Activation | 1 | 2012 | 1132 | 0.270 |
Why?
| | Infertility, Male | 4 | 2013 | 80 | 0.250 |
Why?
| | Germ Cells | 8 | 2004 | 65 | 0.240 |
Why?
| | Spermatogonia | 7 | 2008 | 16 | 0.240 |
Why?
| | Arthritis, Rheumatoid | 2 | 2025 | 1180 | 0.240 |
Why?
| | Ikaros Transcription Factor | 2 | 2023 | 23 | 0.240 |
Why?
| | Receptor, Notch3 | 1 | 2025 | 8 | 0.230 |
Why?
| | Nerve Growth Factors | 2 | 2003 | 78 | 0.230 |
Why?
| | Chemokine CXCL13 | 1 | 2025 | 15 | 0.230 |
Why?
| | Receptors, CXCR3 | 1 | 2025 | 17 | 0.230 |
Why?
| | Receptors, CXCR5 | 1 | 2025 | 27 | 0.230 |
Why?
| | Stromal Cells | 2 | 2025 | 121 | 0.230 |
Why?
| | Chemokine CXCL9 | 1 | 2025 | 38 | 0.230 |
Why?
| | Intestinal Mucosa | 2 | 2023 | 675 | 0.230 |
Why?
| | Electroporation | 2 | 2003 | 43 | 0.230 |
Why?
| | Mice, Inbred C57BL | 19 | 2023 | 5983 | 0.230 |
Why?
| | Chemokine CXCL12 | 1 | 2025 | 86 | 0.220 |
Why?
| | Gene Expression Regulation | 8 | 2021 | 2597 | 0.220 |
Why?
| | Spermatozoa | 8 | 2006 | 106 | 0.220 |
Why?
| | Spondylarthritis | 1 | 2025 | 50 | 0.210 |
Why?
| | Base Sequence | 23 | 2006 | 2170 | 0.200 |
Why?
| | CD8 Antigens | 1 | 2023 | 70 | 0.200 |
Why?
| | Dysbiosis | 1 | 2025 | 187 | 0.200 |
Why?
| | Crystallization | 1 | 2024 | 136 | 0.200 |
Why?
| | T-Lymphocytes | 1 | 2012 | 1996 | 0.200 |
Why?
| | Interleukin-15 | 1 | 2023 | 95 | 0.190 |
Why?
| | Haploidy | 8 | 2003 | 28 | 0.190 |
Why?
| | RNA, Messenger | 20 | 2011 | 2803 | 0.180 |
Why?
| | Zinc Fingers | 4 | 2000 | 50 | 0.180 |
Why?
| | Membrane Proteins | 3 | 2021 | 1164 | 0.180 |
Why?
| | Gene Expression Profiling | 3 | 2025 | 1767 | 0.180 |
Why?
| | Mice, Knockout | 7 | 2023 | 3124 | 0.180 |
Why?
| | Gene Expression | 7 | 2003 | 1476 | 0.180 |
Why?
| | Neuroglia | 1 | 2003 | 173 | 0.180 |
Why?
| | RNA, Small Cytoplasmic | 1 | 2021 | 7 | 0.180 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2022 | 60 | 0.180 |
Why?
| | Granzymes | 1 | 2021 | 49 | 0.170 |
Why?
| | Cell Nucleus | 7 | 2005 | 588 | 0.170 |
Why?
| | Molecular Sequence Data | 21 | 2005 | 2883 | 0.170 |
Why?
| | Spermatids | 7 | 2013 | 25 | 0.170 |
Why?
| | Cell Differentiation | 13 | 2019 | 2046 | 0.160 |
Why?
| | Fibroblasts | 2 | 2025 | 1025 | 0.160 |
Why?
| | Gene Deletion | 1 | 2021 | 391 | 0.160 |
Why?
| | Receptors, Cell Surface | 1 | 2022 | 372 | 0.150 |
Why?
| | Green Fluorescent Proteins | 9 | 2005 | 407 | 0.150 |
Why?
| | Liver | 3 | 2021 | 1896 | 0.150 |
Why?
| | Eosinophils | 1 | 2022 | 316 | 0.150 |
Why?
| | DNA, Complementary | 8 | 2005 | 273 | 0.150 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 919 | 0.150 |
Why?
| | Transcription, Genetic | 13 | 2008 | 1454 | 0.150 |
Why?
| | Palatine Tonsil | 1 | 2019 | 54 | 0.150 |
Why?
| | Myxoma | 1 | 2018 | 11 | 0.140 |
Why?
| | Antigens, CD | 1 | 2021 | 558 | 0.140 |
Why?
| | Heart Neoplasms | 1 | 2018 | 56 | 0.140 |
Why?
| | Male | 46 | 2025 | 72842 | 0.140 |
Why?
| | Luminescent Proteins | 7 | 2003 | 186 | 0.130 |
Why?
| | Cell Line | 9 | 2014 | 2823 | 0.130 |
Why?
| | Heart Atria | 1 | 2018 | 141 | 0.130 |
Why?
| | Proteins | 5 | 2005 | 1023 | 0.130 |
Why?
| | Macrophages | 1 | 2025 | 1507 | 0.130 |
Why?
| | Interleukins | 1 | 2019 | 248 | 0.130 |
Why?
| | Seminiferous Tubules | 6 | 2008 | 13 | 0.130 |
Why?
| | 5-Aminolevulinate Synthetase | 2 | 1997 | 2 | 0.130 |
Why?
| | Amino Acid Sequence | 16 | 2005 | 2129 | 0.130 |
Why?
| | Lymphocytes | 1 | 2019 | 376 | 0.130 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 767 | 0.130 |
Why?
| | Cloning, Molecular | 10 | 2005 | 538 | 0.130 |
Why?
| | Stem Cells | 5 | 2002 | 628 | 0.120 |
Why?
| | Mice, Mutant Strains | 3 | 2003 | 302 | 0.120 |
Why?
| | Promoter Regions, Genetic | 8 | 2011 | 1246 | 0.120 |
Why?
| | Proto-Oncogene Proteins | 3 | 2008 | 624 | 0.120 |
Why?
| | Cyclic AMP Response Element-Binding Protein | 2 | 2006 | 146 | 0.110 |
Why?
| | Blotting, Northern | 11 | 2003 | 203 | 0.110 |
Why?
| | Immunohistochemistry | 10 | 2013 | 1716 | 0.110 |
Why?
| | Cell Proliferation | 2 | 2013 | 2507 | 0.110 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2014 | 14 | 0.110 |
Why?
| | Recombinant Fusion Proteins | 4 | 2013 | 666 | 0.110 |
Why?
| | CD4 Antigens | 1 | 2014 | 137 | 0.100 |
Why?
| | Cell Division | 5 | 2003 | 756 | 0.100 |
Why?
| | Exons | 9 | 2011 | 363 | 0.100 |
Why?
| | Monomeric Clathrin Assembly Proteins | 1 | 2013 | 5 | 0.100 |
Why?
| | Acrosome | 1 | 2013 | 6 | 0.100 |
Why?
| | trans-Golgi Network | 1 | 2013 | 15 | 0.100 |
Why?
| | Th17 Cells | 1 | 2014 | 101 | 0.100 |
Why?
| | Signal Transduction | 3 | 2025 | 5216 | 0.100 |
Why?
| | Zymosan | 1 | 2013 | 39 | 0.100 |
Why?
| | Carbolines | 1 | 2013 | 35 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2013 | 88 | 0.090 |
Why?
| | Stem Cell Factor | 3 | 2002 | 16 | 0.090 |
Why?
| | Protein Transport | 2 | 2013 | 442 | 0.090 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2013 | 40 | 0.090 |
Why?
| | Culture Media | 1 | 2013 | 161 | 0.090 |
Why?
| | Humans | 26 | 2025 | 145474 | 0.090 |
Why?
| | Genes, Bacterial | 1 | 1993 | 152 | 0.090 |
Why?
| | Child, Preschool | 2 | 2025 | 11853 | 0.090 |
Why?
| | Biomarkers | 3 | 2021 | 4295 | 0.090 |
Why?
| | Microcirculation | 1 | 2013 | 142 | 0.090 |
Why?
| | RNA, Small Interfering | 1 | 2014 | 637 | 0.090 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2013 | 364 | 0.090 |
Why?
| | Receptors, Antigen, T-Cell, alpha-beta | 1 | 2013 | 334 | 0.080 |
Why?
| | Quality Improvement | 1 | 2020 | 1295 | 0.080 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2012 | 337 | 0.080 |
Why?
| | Spleen | 1 | 2013 | 508 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 6 | 2008 | 910 | 0.080 |
Why?
| | Nuclear Proteins | 3 | 2003 | 740 | 0.080 |
Why?
| | Autophagy | 1 | 2013 | 291 | 0.080 |
Why?
| | Gene Library | 8 | 2003 | 122 | 0.080 |
Why?
| | Actins | 2 | 2003 | 425 | 0.080 |
Why?
| | In Situ Hybridization | 8 | 2004 | 318 | 0.080 |
Why?
| | Meiosis | 2 | 2003 | 101 | 0.080 |
Why?
| | Cytoplasm | 4 | 2005 | 254 | 0.080 |
Why?
| | Inflammation Mediators | 1 | 2013 | 506 | 0.080 |
Why?
| | Lymph Nodes | 1 | 2013 | 503 | 0.080 |
Why?
| | Histones | 3 | 2006 | 666 | 0.080 |
Why?
| | Heat-Shock Proteins | 3 | 2006 | 139 | 0.080 |
Why?
| | Female | 16 | 2025 | 78844 | 0.080 |
Why?
| | Estrogen Receptor alpha | 1 | 2011 | 151 | 0.070 |
Why?
| | Cell Membrane | 1 | 2013 | 707 | 0.070 |
Why?
| | Testicular Neoplasms | 2 | 2003 | 111 | 0.070 |
Why?
| | Basic-Leucine Zipper Transcription Factors | 2 | 2006 | 43 | 0.070 |
Why?
| | Genes, Reporter | 6 | 2013 | 277 | 0.070 |
Why?
| | Blotting, Western | 6 | 2013 | 1179 | 0.070 |
Why?
| | Adolescent | 2 | 2025 | 22529 | 0.070 |
Why?
| | Flow Cytometry | 1 | 2012 | 1162 | 0.070 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2014 | 1140 | 0.070 |
Why?
| | Burns | 1 | 2013 | 374 | 0.070 |
Why?
| | Cells, Cultured | 4 | 2019 | 4148 | 0.070 |
Why?
| | Child | 2 | 2025 | 22707 | 0.070 |
Why?
| | Matrix Metalloproteinase 9 | 1 | 2008 | 131 | 0.060 |
Why?
| | Mouth Neoplasms | 1 | 2008 | 90 | 0.060 |
Why?
| | Response Elements | 2 | 2005 | 86 | 0.060 |
Why?
| | Endoplasmic Reticulum | 2 | 2006 | 264 | 0.060 |
Why?
| | Peptides | 1 | 2013 | 998 | 0.060 |
Why?
| | Protein Biosynthesis | 5 | 2003 | 452 | 0.060 |
Why?
| | Alternative Splicing | 3 | 2011 | 247 | 0.060 |
Why?
| | Glial Cell Line-Derived Neurotrophic Factor | 2 | 2003 | 17 | 0.060 |
Why?
| | Cyclic AMP Response Element Modulator | 1 | 2006 | 3 | 0.060 |
Why?
| | Receptors, Androgen | 2 | 2005 | 148 | 0.060 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2006 | 108 | 0.060 |
Why?
| | Sperm Tail | 2 | 2002 | 8 | 0.060 |
Why?
| | Recombinant Proteins | 3 | 2005 | 1368 | 0.060 |
Why?
| | Nucleocytoplasmic Transport Proteins | 1 | 2005 | 9 | 0.060 |
Why?
| | Chromosome Mapping | 5 | 2011 | 506 | 0.060 |
Why?
| | Gene Targeting | 3 | 2013 | 81 | 0.060 |
Why?
| | Erythroid-Specific DNA-Binding Factors | 4 | 2003 | 17 | 0.060 |
Why?
| | Glycoside Hydrolases | 1 | 2005 | 38 | 0.060 |
Why?
| | Bacterial Translocation | 1 | 2025 | 52 | 0.050 |
Why?
| | GATA1 Transcription Factor | 4 | 2003 | 18 | 0.050 |
Why?
| | Mice, Transgenic | 7 | 2005 | 2188 | 0.050 |
Why?
| | Multigene Family | 1 | 2005 | 210 | 0.050 |
Why?
| | Immunity, Mucosal | 1 | 2025 | 98 | 0.050 |
Why?
| | Genes | 2 | 2003 | 227 | 0.050 |
Why?
| | Olfactory Receptor Neurons | 1 | 2004 | 41 | 0.050 |
Why?
| | GATA4 Transcription Factor | 1 | 2004 | 19 | 0.050 |
Why?
| | Mice, Inbred ICR | 1 | 2004 | 113 | 0.050 |
Why?
| | Mitochondrial ADP, ATP Translocases | 1 | 2003 | 2 | 0.050 |
Why?
| | Follicle Stimulating Hormone | 2 | 2002 | 266 | 0.050 |
Why?
| | Up-Regulation | 2 | 2004 | 847 | 0.050 |
Why?
| | Phosphoric Monoester Hydrolases | 1 | 2003 | 56 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 641 | 0.050 |
Why?
| | Genetic Engineering | 1 | 2003 | 88 | 0.050 |
Why?
| | Sperm Count | 1 | 2002 | 22 | 0.050 |
Why?
| | DNA, Circular | 1 | 2002 | 15 | 0.050 |
Why?
| | Phylogeny | 3 | 2005 | 917 | 0.050 |
Why?
| | Procollagen | 1 | 2002 | 24 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2013 | 1789 | 0.050 |
Why?
| | HeLa Cells | 4 | 2006 | 632 | 0.050 |
Why?
| | Sequence Homology, Amino Acid | 5 | 2001 | 387 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 977 | 0.050 |
Why?
| | DNA Damage | 1 | 2005 | 437 | 0.050 |
Why?
| | Prostatic Intraepithelial Neoplasia | 1 | 2002 | 9 | 0.050 |
Why?
| | Spermatocytes | 2 | 2005 | 18 | 0.050 |
Why?
| | Teratoma | 1 | 2003 | 124 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2008 | 1443 | 0.040 |
Why?
| | Tissue Distribution | 4 | 2004 | 335 | 0.040 |
Why?
| | Leukocyte Count | 1 | 2022 | 316 | 0.040 |
Why?
| | DNA | 5 | 2013 | 1435 | 0.040 |
Why?
| | Immunomodulation | 1 | 2022 | 99 | 0.040 |
Why?
| | Molecular Chaperones | 2 | 2006 | 199 | 0.040 |
Why?
| | RNA-Binding Proteins | 1 | 2005 | 447 | 0.040 |
Why?
| | Coenzyme A-Transferases | 1 | 2000 | 1 | 0.040 |
Why?
| | Leydig Cells | 2 | 1998 | 15 | 0.040 |
Why?
| | Drosophila Proteins | 2 | 2001 | 213 | 0.040 |
Why?
| | Intestine, Small | 1 | 2022 | 167 | 0.040 |
Why?
| | Tumor Suppressor Proteins | 1 | 2003 | 321 | 0.040 |
Why?
| | Androgen-Binding Protein | 1 | 2000 | 1 | 0.040 |
Why?
| | Ovary | 1 | 2002 | 233 | 0.040 |
Why?
| | Genetic Therapy | 1 | 2002 | 316 | 0.040 |
Why?
| | Ligands | 1 | 2022 | 665 | 0.040 |
Why?
| | Rats | 7 | 1999 | 5584 | 0.040 |
Why?
| | Food Hypersensitivity | 1 | 2022 | 164 | 0.040 |
Why?
| | Eosinophilia | 1 | 2022 | 223 | 0.040 |
Why?
| | Testicular Hormones | 1 | 1999 | 8 | 0.040 |
Why?
| | Collagen | 1 | 2002 | 457 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2000 | 72 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-ets | 3 | 2008 | 56 | 0.040 |
Why?
| | Binding Sites | 4 | 2006 | 1310 | 0.040 |
Why?
| | Protein Isoforms | 3 | 2011 | 397 | 0.040 |
Why?
| | Purpura | 1 | 2018 | 18 | 0.040 |
Why?
| | Prostate | 1 | 2000 | 158 | 0.040 |
Why?
| | Chromatin | 1 | 2003 | 553 | 0.040 |
Why?
| | Sequence Analysis, DNA | 4 | 2005 | 777 | 0.030 |
Why?
| | Nerve Tissue Proteins | 1 | 2002 | 591 | 0.030 |
Why?
| | Exanthema | 1 | 2018 | 86 | 0.030 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 100 | 0.030 |
Why?
| | Luciferases | 3 | 2005 | 153 | 0.030 |
Why?
| | Anemia, Sideroblastic | 1 | 1997 | 4 | 0.030 |
Why?
| | Transferrin | 1 | 1997 | 50 | 0.030 |
Why?
| | Cell Lineage | 1 | 1999 | 377 | 0.030 |
Why?
| | X Chromosome | 1 | 1997 | 65 | 0.030 |
Why?
| | Endopeptidases | 1 | 1997 | 80 | 0.030 |
Why?
| | Testosterone | 1 | 2001 | 416 | 0.030 |
Why?
| | Pyridoxine | 1 | 1997 | 37 | 0.030 |
Why?
| | Erythropoiesis | 1 | 1997 | 57 | 0.030 |
Why?
| | Fever | 1 | 2018 | 319 | 0.030 |
Why?
| | Regulatory Sequences, Nucleic Acid | 1 | 1997 | 92 | 0.030 |
Why?
| | Nucleic Acid Hybridization | 2 | 1997 | 187 | 0.030 |
Why?
| | Recombination, Genetic | 1 | 1998 | 203 | 0.030 |
Why?
| | Phosphoprotein Phosphatases | 1 | 1996 | 66 | 0.030 |
Why?
| | Introns | 4 | 1999 | 255 | 0.030 |
Why?
| | Point Mutation | 1 | 1997 | 240 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 364 | 0.030 |
Why?
| | Intercellular Signaling Peptides and Proteins | 2 | 1999 | 376 | 0.030 |
Why?
| | Echocardiography | 1 | 2018 | 647 | 0.030 |
Why?
| | Crosses, Genetic | 2 | 2008 | 123 | 0.030 |
Why?
| | Prostatic Neoplasms | 1 | 2002 | 978 | 0.030 |
Why?
| | Microscopy, Fluorescence | 3 | 2000 | 408 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 2018 | 1508 | 0.030 |
Why?
| | Clathrin-Coated Vesicles | 1 | 2013 | 5 | 0.020 |
Why?
| | Syntaxin 1 | 1 | 2013 | 14 | 0.020 |
Why?
| | Sperm Motility | 2 | 2004 | 37 | 0.020 |
Why?
| | Clathrin | 1 | 2013 | 26 | 0.020 |
Why?
| | Tadalafil | 1 | 2013 | 6 | 0.020 |
Why?
| | Chemotactic Factors | 1 | 1993 | 43 | 0.020 |
Why?
| | Dimerization | 2 | 2006 | 189 | 0.020 |
Why?
| | TATA Box | 1 | 1993 | 20 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 1993 | 68 | 0.020 |
Why?
| | Survival | 1 | 2013 | 38 | 0.020 |
Why?
| | Growth Substances | 1 | 1993 | 138 | 0.020 |
Why?
| | Pain | 1 | 2018 | 789 | 0.020 |
Why?
| | Biological Transport | 2 | 2005 | 424 | 0.020 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 1996 | 414 | 0.020 |
Why?
| | Cricetinae | 2 | 2005 | 305 | 0.020 |
Why?
| | In Vitro Techniques | 2 | 2006 | 1048 | 0.020 |
Why?
| | Aging | 4 | 2008 | 1969 | 0.020 |
Why?
| | Apoptosis | 3 | 2006 | 2440 | 0.020 |
Why?
| | Microscopy, Confocal | 1 | 2013 | 319 | 0.020 |
Why?
| | Rats, Wistar | 1 | 1993 | 450 | 0.020 |
Why?
| | Species Specificity | 2 | 2005 | 546 | 0.020 |
Why?
| | Anemia | 1 | 1993 | 191 | 0.020 |
Why?
| | Random Amplified Polymorphic DNA Technique | 1 | 2011 | 4 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 2013 | 514 | 0.020 |
Why?
| | Protein Structure, Tertiary | 2 | 2005 | 855 | 0.020 |
Why?
| | Blotting, Southern | 2 | 2001 | 85 | 0.020 |
Why?
| | Organ Specificity | 2 | 2002 | 309 | 0.020 |
Why?
| | Wound Healing | 1 | 2013 | 355 | 0.020 |
Why?
| | Cell Fractionation | 2 | 2000 | 50 | 0.020 |
Why?
| | Mice, Inbred Strains | 2 | 2001 | 396 | 0.020 |
Why?
| | DNA Primers | 2 | 2003 | 505 | 0.020 |
Why?
| | Cell Cycle | 2 | 2005 | 598 | 0.020 |
Why?
| | Transcriptional Activation | 2 | 2005 | 372 | 0.020 |
Why?
| | Gestational Age | 1 | 1993 | 987 | 0.020 |
Why?
| | Mice, Inbred BALB C | 2 | 2003 | 1261 | 0.020 |
Why?
| | HEK293 Cells | 1 | 2011 | 741 | 0.020 |
Why?
| | Heterozygote | 1 | 2008 | 313 | 0.020 |
Why?
| | Organ Size | 1 | 2008 | 461 | 0.020 |
Why?
| | Cell Movement | 2 | 2004 | 959 | 0.020 |
Why?
| | Animals, Newborn | 2 | 2003 | 891 | 0.020 |
Why?
| | Fertility | 1 | 2008 | 173 | 0.020 |
Why?
| | Neutrophils | 1 | 1993 | 1124 | 0.020 |
Why?
| | Models, Genetic | 2 | 2000 | 524 | 0.020 |
Why?
| | Rats, Inbred F344 | 2 | 1998 | 268 | 0.020 |
Why?
| | Intracellular Signaling Peptides and Proteins | 2 | 2001 | 456 | 0.020 |
Why?
| | Time Factors | 3 | 2004 | 7123 | 0.020 |
Why?
| | Protein Binding | 2 | 2005 | 2238 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 506 | 0.010 |
Why?
| | Histone Chaperones | 1 | 2006 | 15 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 2006 | 414 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2018 | 3904 | 0.010 |
Why?
| | Cycloheximide | 1 | 2005 | 42 | 0.010 |
Why?
| | Leucine Zippers | 1 | 2005 | 13 | 0.010 |
Why?
| | Caspases | 1 | 2006 | 233 | 0.010 |
Why?
| | Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2005 | 14 | 0.010 |
Why?
| | Gene Components | 1 | 2005 | 6 | 0.010 |
Why?
| | Hydroxyurea | 1 | 2005 | 34 | 0.010 |
Why?
| | Bone Marrow | 2 | 1997 | 306 | 0.010 |
Why?
| | Chloramphenicol O-Acetyltransferase | 1 | 2005 | 35 | 0.010 |
Why?
| | Neurospora crassa | 1 | 2005 | 23 | 0.010 |
Why?
| | Cricetulus | 1 | 2005 | 118 | 0.010 |
Why?
| | Half-Life | 1 | 2005 | 155 | 0.010 |
Why?
| | Metribolone | 1 | 2005 | 3 | 0.010 |
Why?
| | Histidine | 1 | 2005 | 66 | 0.010 |
Why?
| | Nuclear Pore Complex Proteins | 1 | 2005 | 40 | 0.010 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2005 | 88 | 0.010 |
Why?
| | Adherens Junctions | 1 | 2005 | 24 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2005 | 148 | 0.010 |
Why?
| | HSP40 Heat-Shock Proteins | 1 | 2005 | 25 | 0.010 |
Why?
| | Sperm-Ovum Interactions | 1 | 2004 | 12 | 0.010 |
Why?
| | Glycosylation | 1 | 2005 | 173 | 0.010 |
Why?
| | Flagella | 1 | 2004 | 27 | 0.010 |
Why?
| | Sequence Deletion | 1 | 2005 | 190 | 0.010 |
Why?
| | RNA | 2 | 2001 | 910 | 0.010 |
Why?
| | Fertilization | 1 | 2004 | 43 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 362 | 0.010 |
Why?
| | Receptors, Odorant | 1 | 2004 | 32 | 0.010 |
Why?
| | Chemotaxis | 1 | 2004 | 122 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 207 | 0.010 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2005 | 192 | 0.010 |
Why?
| | Transcription Initiation Site | 1 | 2003 | 43 | 0.010 |
Why?
| | Genetic Vectors | 1 | 2005 | 335 | 0.010 |
Why?
| | Mitochondria | 2 | 2003 | 992 | 0.010 |
Why?
| | Ornithine Carbamoyltransferase | 1 | 2003 | 3 | 0.010 |
Why?
| | DNA Replication | 1 | 2005 | 249 | 0.010 |
Why?
| | Models, Chemical | 1 | 2004 | 250 | 0.010 |
Why?
| | Protamines | 1 | 2003 | 8 | 0.010 |
Why?
| | HSP47 Heat-Shock Proteins | 1 | 2002 | 6 | 0.010 |
Why?
| | Cell Culture Techniques | 1 | 2005 | 372 | 0.010 |
Why?
| | Seminal Plasma Proteins | 1 | 2002 | 11 | 0.010 |
Why?
| | Restriction Mapping | 1 | 2002 | 81 | 0.010 |
Why?
| | Neoplasm Transplantation | 1 | 2003 | 246 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2013 | 4560 | 0.010 |
Why?
| | Ultraviolet Rays | 1 | 2005 | 384 | 0.010 |
Why?
| | Cytoskeletal Proteins | 1 | 2003 | 156 | 0.010 |
Why?
| | Base Pairing | 1 | 2002 | 65 | 0.010 |
Why?
| | Subcellular Fractions | 1 | 2002 | 73 | 0.010 |
Why?
| | Genome | 1 | 2005 | 305 | 0.010 |
Why?
| | Isoenzymes | 1 | 2003 | 294 | 0.010 |
Why?
| | Protein Processing, Post-Translational | 1 | 2005 | 471 | 0.010 |
Why?
| | Octamer Transcription Factor-3 | 1 | 2002 | 19 | 0.010 |
Why?
| | Embryo, Mammalian | 1 | 2003 | 234 | 0.010 |
Why?
| | COS Cells | 1 | 2002 | 177 | 0.010 |
Why?
| | Bromodeoxyuridine | 1 | 2002 | 77 | 0.010 |
Why?
| | Enhancer Elements, Genetic | 1 | 2003 | 191 | 0.010 |
Why?
| | Cell Cycle Proteins | 1 | 2006 | 630 | 0.010 |
Why?
| | RNA-Induced Silencing Complex | 1 | 2001 | 7 | 0.010 |
Why?
| | PTEN Phosphohydrolase | 1 | 2003 | 165 | 0.010 |
Why?
| | Flutamide | 1 | 2001 | 7 | 0.010 |
Why?
| | Argonaute Proteins | 1 | 2001 | 32 | 0.010 |
Why?
| | Prostatic Hyperplasia | 1 | 2002 | 40 | 0.010 |
Why?
| | Androgen Receptor Antagonists | 1 | 2001 | 35 | 0.010 |
Why?
| | Dipeptides | 1 | 2001 | 56 | 0.010 |
Why?
| | Mice, Nude | 1 | 2003 | 679 | 0.010 |
Why?
| | Fanconi Anemia Complementation Group Proteins | 1 | 2000 | 6 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2000 | 90 | 0.010 |
Why?
| | Phosphorylation | 1 | 2005 | 1707 | 0.010 |
Why?
| | Escherichia coli | 1 | 2005 | 835 | 0.010 |
Why?
| | Sequence Homology, Nucleic Acid | 1 | 2000 | 157 | 0.010 |
Why?
| | Androgen Antagonists | 1 | 2001 | 91 | 0.010 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2001 | 325 | 0.010 |
Why?
| | Phospholipid Transfer Proteins | 1 | 2000 | 7 | 0.010 |
Why?
| | Luteinizing Hormone | 1 | 2001 | 207 | 0.010 |
Why?
| | Sequence Homology | 1 | 2000 | 43 | 0.010 |
Why?
| | Ornithine Decarboxylase Inhibitors | 1 | 2000 | 5 | 0.010 |
Why?
| | Ornithine Decarboxylase | 1 | 2000 | 13 | 0.010 |
Why?
| | Basement Membrane | 1 | 2000 | 32 | 0.010 |
Why?
| | Frameshifting, Ribosomal | 1 | 2000 | 9 | 0.010 |
Why?
| | Pancreas | 1 | 2003 | 341 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2004 | 2028 | 0.010 |
Why?
| | Polyamines | 1 | 2000 | 42 | 0.010 |
Why?
| | CHO Cells | 1 | 2000 | 169 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2008 | 3542 | 0.010 |
Why?
| | CapZ Actin Capping Protein | 1 | 1999 | 2 | 0.010 |
Why?
| | Pregnancy | 1 | 1993 | 7202 | 0.010 |
Why?
| | Peptide Fragments | 1 | 2003 | 693 | 0.010 |
Why?
| | Mutation | 2 | 2002 | 4075 | 0.010 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2001 | 217 | 0.010 |
Why?
| | Gonads | 1 | 1999 | 22 | 0.010 |
Why?
| | Plasmids | 1 | 2000 | 373 | 0.010 |
Why?
| | Open Reading Frames | 1 | 2000 | 130 | 0.010 |
Why?
| | Inbreeding | 1 | 1999 | 20 | 0.010 |
Why?
| | CpG Islands | 1 | 1999 | 163 | 0.010 |
Why?
| | Stem Cell Transplantation | 1 | 2000 | 189 | 0.010 |
Why?
| | Calcium | 1 | 2004 | 1190 | 0.010 |
Why?
| | Rabbits | 1 | 1999 | 652 | 0.010 |
Why?
| | Selenoprotein P | 1 | 1998 | 3 | 0.010 |
Why?
| | Mesylates | 1 | 1998 | 7 | 0.010 |
Why?
| | Selenoproteins | 1 | 1998 | 7 | 0.010 |
Why?
| | 3-Hydroxysteroid Dehydrogenases | 1 | 1997 | 8 | 0.010 |
Why?
| | Receptors, LH | 1 | 1997 | 9 | 0.010 |
Why?
| | Cathepsin L | 1 | 1997 | 9 | 0.010 |
Why?
| | Clusterin | 1 | 1997 | 12 | 0.010 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2000 | 337 | 0.010 |
Why?
| | Cathepsins | 1 | 1997 | 24 | 0.010 |
Why?
| | Erythroid Precursor Cells | 1 | 1997 | 5 | 0.010 |
Why?
| | Yolk Sac | 1 | 1997 | 5 | 0.010 |
Why?
| | Drosophila melanogaster | 1 | 1999 | 237 | 0.010 |
Why?
| | Cysteine Endopeptidases | 1 | 1997 | 78 | 0.010 |
Why?
| | Kidney | 1 | 2005 | 1497 | 0.010 |
Why?
| | Embryonic and Fetal Development | 1 | 1997 | 93 | 0.010 |
Why?
| | Aspartic Acid | 1 | 1997 | 88 | 0.010 |
Why?
| | Valine | 1 | 1997 | 83 | 0.010 |
Why?
| | Protein Phosphatase 2C | 1 | 1996 | 15 | 0.010 |
Why?
| | Genetic Markers | 1 | 1997 | 335 | 0.010 |
Why?
| | Protein Phosphatase 2 | 1 | 1996 | 41 | 0.010 |
Why?
| | Phenotype | 1 | 2005 | 3155 | 0.010 |
Why?
| | Conserved Sequence | 1 | 1997 | 244 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2000 | 728 | 0.010 |
Why?
| | Substrate Specificity | 1 | 1996 | 387 | 0.010 |
Why?
| | Glycoproteins | 1 | 1997 | 354 | 0.010 |
Why?
| | Models, Biological | 1 | 2002 | 1764 | 0.010 |
Why?
| | Kinetics | 1 | 1998 | 1567 | 0.010 |
Why?
| | Antioxidants | 1 | 1998 | 550 | 0.010 |
Why?
| | Epithelial Cells | 1 | 2000 | 1131 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 1997 | 1471 | 0.010 |
Why?
| | Chemokine CXCL1 | 1 | 1993 | 76 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 1997 | 3413 | 0.000 |
Why?
| | Aged | 1 | 2002 | 26153 | 0.000 |
Why?
| | Middle Aged | 1 | 2002 | 36215 | 0.000 |
Why?
|
|
Yomogida's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|